Mucipoly AB Tablet – Acebrophylline 100mg & Acetylcysteine 600mg

WHO-GMP Certified Respiratory Medicine from Cafoli Lifecare Respihub Division

PCD Pharma Franchise Opportunity for Respiratory Medicine Distribution

Manufactured by WHO-GMP Compliant Facility for Consistent Product Quality

Acebrophylline + Acetylcysteine In phama franchise company in India.
Ethical Manufacturing, Reliable Supply Chain, and Trade-Focused Support

Home/Products /acebrophylline-100mg-acetylcysteine-600mg-tablet

Mucipoly AB Tablet

Composition : Each tablet contains: Acebrophylline I.P. 100 mg Acetylcysteine I.P. 600 mg Excipients q.s.

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*15

Price : ₹337/-

Please Contact For Best Price

Manufacturing & Quality Standards

Mucipoly AB is manufactured by Akums, a well-established pharmaceutical manufacturer operating under WHO-GMP compliant facilities. The product is produced following standardized manufacturing protocols, batch-wise quality checks, and regulated documentation practices. This ensures consistent quality, reliability, and suitability for pharmaceutical trade distribution across India.

Product Overview

Mucipoly AB is a branded pharmaceutical formulation developed for respiratory care portfolios under Cafoli Lifecare’s Respihub division. The product is positioned specifically for PCD pharma franchise distribution, wholesale supply, and institutional trade channels.

The formulation is developed with a strong focus on:

  • Consistent batch-to-batch quality
  • Accurate and transparent composition labeling
  • Professional-grade pharmaceutical packaging
  • Compliance with Indian pharmaceutical regulations

These factors make Mucipoly AB suitable for long-term inclusion in respiratory product ranges managed by distributors and franchise partners.

Packaging Details

  • Strip packing with standardized tablet presentation
  • Secure outer carton with complete statutory labeling information
  • Packaging designed for safe logistics handling and efficient inventory storage

Target Trade Segment (B2B)

  • PCD Pharma Franchise Partners
  • Pharmaceutical Distributors & Stockists
  • Institutional and Bulk Medicine Supply
  • Hospital and Clinic Supply Chains

This product is not positioned for direct-to-consumer sale and is supplied strictly through pharmaceutical trade channels.

Availability & Supply

Mucipoly AB is supplied through Cafoli Lifecare’s structured distribution network, ensuring:

  • Reliable and consistent stock availability
  • Transparent and defined dispatch timelines
  • Clear documentation and GST-compliant invoicing
  • Trade-supportive MOQ options for franchise partners

Why Include Mucipoly AB in Your Respiratory Portfolio

  • Manufactured by a trusted WHO-GMP compliant manufacturer
  • Consistent formulation and packaging quality
  • Part of Cafoli Lifecare’s focused Respihub respiratory division
  • Suitable for long-term distributor portfolio building
  • Backed by ethical marketing and compliance-driven business practices

Read More

About the Product

Manufacturing & Quality Standards

Mucipoly AB is manufactured by Akums, a well-established pharmaceutical manufacturer operating under WHO-GMP compliant facilities. The product is produced following standardized manufacturing protocols, batch-wise quality checks, and regulated documentation practices. This ensures consistent quality, reliability, and suitability for pharmaceutical trade distribution across India.

Product Overview

Mucipoly AB is a branded pharmaceutical formulation developed for respiratory care portfolios under Cafoli Lifecare’s Respihub division. The product is positioned specifically for PCD pharma franchise distribution, wholesale supply, and institutional trade channels.

The formulation is developed with a strong focus on:

  • Consistent batch-to-batch quality
  • Accurate and transparent composition labeling
  • Professional-grade pharmaceutical packaging
  • Compliance with Indian pharmaceutical regulations

These factors make Mucipoly AB suitable for long-term inclusion in respiratory product ranges managed by distributors and franchise partners.

Packaging Details

  • Strip packing with standardized tablet presentation
  • Secure outer carton with complete statutory labeling information
  • Packaging designed for safe logistics handling and efficient inventory storage

Target Trade Segment (B2B)

  • PCD Pharma Franchise Partners
  • Pharmaceutical Distributors & Stockists
  • Institutional and Bulk Medicine Supply
  • Hospital and Clinic Supply Chains

This product is not positioned for direct-to-consumer sale and is supplied strictly through pharmaceutical trade channels.

Availability & Supply

Mucipoly AB is supplied through Cafoli Lifecare’s structured distribution network, ensuring:

  • Reliable and consistent stock availability
  • Transparent and defined dispatch timelines
  • Clear documentation and GST-compliant invoicing
  • Trade-supportive MOQ options for franchise partners

Why Include Mucipoly AB in Your Respiratory Portfolio

  • Manufactured by a trusted WHO-GMP compliant manufacturer
  • Consistent formulation and packaging quality
  • Part of Cafoli Lifecare’s focused Respihub respiratory division
  • Suitable for long-term distributor portfolio building
  • Backed by ethical marketing and compliance-driven business practices

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Mucipoly A Tablet treats and prevents asthma and COPD symptoms by relaxing airway muscles for easier breathing.

**Disclaimer:** This product information is intended solely for pharmaceutical trade professionals, distributors, and PCD pharma franchise partners. Mucipoly AB is not promoted for direct consumer sale. All details provided are for informational and business reference purposes only and comply with applicable pharmaceutical regulations in India.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch